The conversion of an inhibitory signal to an activating signal not only made these NK cells resistant to TGF-β but also led to increased NK cell activation and improved tumor control in a model of TGF-β secreting neuroblastoma [209]. The gene discussed is TGFB1; the disease is neoplasm.